worldwid
million
individu
chronic
infect
hepat
c
viru
hcv
positivestrand
rna
viru
infect
liver
although
acut
infect
typic
asymptomat
patient
fail
clear
viru
result
chronic
infect
associ
develop
signific
liver
diseas
fibrosi
cirrhosi
steatosi
insulin
resist
hepatocellular
carcinoma
hcc
fact
hcvrelat
hcc
account
hcc
case
liver
transplant
unit
state
despit
obviou
public
health
burden
vaccin
prevent
infect
current
interferonbas
treatment
option
toxic
side
effect
limit
efficaci
main
obstacl
imped
hcv
research
antivir
drug
develop
sinc
discoveri
lack
robust
infecti
cell
cultur
system
capabl
recapitul
aspect
viral
lifecycl
although
earli
advanc
studi
hcv
made
use
surrog
system
replicon
hcv
pseudotyp
particl
hcvpp
develop
cellcultur
deriv
hcv
hcvcc
system
robust
hcv
infect
final
achiev
vitro
system
base
identif
hcv
genotyp
molecular
clone
shown
capabl
replic
assembl
infecti
particl
cell
cultur
discoveri
human
hepatoma
cell
line
permiss
hcv
infect
although
numer
human
hepatoma
cell
line
exist
cell
hepatoma
cell
line
rigor
test
hcvcc
permiss
date
vari
degre
success
identif
cell
line
abl
support
hcv
infect
would
expand
current
repertoir
cell
line
avail
studi
hcv
could
also
prove
use
identif
cellular
determin
hcv
infect
identifi
cell
line
suitabl
hcv
infect
studi
assembl
panel
hepat
nonhepat
cell
line
assess
permiss
hcv
infect
show
hcvcc
infect
ie
replic
protein
translat
de
novo
virion
product
human
hepatoma
cell
line
like
cell
plc
cell
human
hepatoma
cell
line
first
isol
earli
cell
human
hepatoma
cell
line
deriv
hepatocellular
carcinoma
isol
year
old
male
previous
util
hcv
entri
hcvpp
studi
howev
knowledg
hcvcc
infect
rna
replic
two
cell
line
absenc
complement
previous
report
although
numer
group
assess
permiss
multipl
cell
line
hcvpp
infect
sinc
develop
hcv
infecti
cell
cultur
system
comprehens
analysi
permiss
human
hepat
nonhepat
cell
line
hcvcc
infect
yet
report
identif
altern
cell
line
support
robust
hcvcc
infect
still
warrant
thu
compil
panel
human
cell
line
hepat
nonhepat
origin
tabl
routin
use
hcvpp
entri
assess
permiss
hcvcc
infect
first
control
hcvpp
infect
cell
infect
pseudotyp
lentivirus
encod
luciferas
report
bear
glycoprotein
hcv
genotyp
jfhpp
hcv
genotyp
vsv
g
glycoprotein
vsvgpp
h
post
infect
pi
pseudoparticl
entri
assess
luciferas
activ
previous
describ
cell
line
equal
permiss
vsvgpp
infect
rlu
data
shown
howev
plc
cell
stabli
express
addit
file
figur
permiss
hcvpp
infect
figur
cell
line
test
exhibit
less
maximum
luciferas
activ
indic
cell
nonpermiss
hcvpp
entri
consist
previous
publish
report
assess
permiss
hcvcc
infect
cell
infect
hcvcc
moi
ffucel
intracellular
hcv
rna
determin
rtqpcr
analysi
h
pi
includ
chines
hamster
ovari
cell
lack
known
hcv
entri
receptor
therefor
serv
control
background
hcv
rna
level
ie
nonspecif
cell
bound
hcv
figur
dash
line
rna
expect
cell
highli
permiss
hcvcc
replic
hcv
rna
level
rna
h
pi
cell
show
minim
hcvcc
permiss
reach
level
rna
although
cell
previous
report
support
suboptim
hcvcc
infect
low
level
hcv
rna
p
valu
measur
infect
cultur
like
due
receptorbound
hcv
similar
nonpermiss
parent
cell
line
addit
cell
confer
hcvcc
permiss
previous
report
result
increas
hcv
rna
replic
rna
p
valu
notabl
statist
signific
hcvcc
infect
also
detect
plc
cell
cell
although
plc
cell
less
permiss
hcvpp
figur
plc
cell
contain
higher
hcv
rna
level
rna
h
infect
hcvcc
compar
cell
rna
figur
permiss
cell
hcvpp
infect
figur
taken
togeth
data
indic
plc
cell
permiss
hcvpp
hcvcc
infect
although
permiss
hcvcc
hcvpp
infect
reduc
differ
degre
compar
cell
suggest
plc
cell
may
differ
capac
effici
support
specif
aspect
hcv
lifecycl
thu
initi
experi
systemat
dissect
plc
permiss
hcvcc
infect
focus
separ
step
viral
lifecycl
plc
cell
cell
cell
hepatomaderiv
cell
line
although
differ
cytolog
one
anoth
share
similar
hepatocyteslik
characterist
cell
cuboid
epitheliallik
morpholog
high
nucleustocytoplasm
ratio
contain
mono
binuclei
multipl
nucleoli
cytoplasm
granul
addit
file
figur
initi
screen
figur
indic
three
cell
line
also
share
permiss
hcvpp
hcvcc
infect
albeit
differ
degre
sinc
viral
bindingentri
repres
first
step
hcv
lifecycl
first
assess
express
known
hcv
entri
factor
cell
measur
srbi
ocln
mrna
level
rtqpcr
analysi
figur
compar
signific
differ
mrna
express
four
known
hcv
entri
factor
observ
among
four
cell
line
next
analyz
cell
surfac
express
srbi
flow
cytometri
ocln
indirect
immunofluoresc
commerciallyavail
antibodi
two
tight
junction
protein
amend
flow
cytometr
analysi
shown
figur
cell
surfac
express
srbi
plc
cell
measur
flow
cytometri
compar
observ
cell
analysi
ocln
also
confirm
cell
surfac
express
receptor
newli
identifi
hcvccpermiss
plc
cell
well
previous
character
cell
taken
togeth
data
indic
plc
cell
minimum
express
local
four
known
hcv
entri
receptor
cell
surfac
despit
express
four
previous
establish
essenti
hcv
entri
factor
plc
cell
show
reduc
permiss
hcvpp
infect
figur
compar
cell
vari
luciferas
activ
parallel
hcvpp
inocul
phenotyp
seen
among
cell
line
differ
laboratori
addit
file
figur
function
test
whether
cell
express
suboptim
level
known
hcv
entri
factor
transient
transfect
plc
cell
vector
express
four
known
human
hcv
receptor
reassess
permiss
hcvpp
hcvcc
infect
h
posttransfect
shown
express
hcv
entri
factor
tran
individu
figur
combin
data
shown
enhanc
hcvpp
figur
hcvcc
figur
infect
plc
cell
henc
less
luciferas
activ
gener
plc
cell
inocul
hcvpp
compar
cell
due
suboptim
express
known
hcv
entri
factor
defect
post
entri
step
reduc
hcv
rna
replic
neg
affect
hcvcc
infect
even
entri
achiev
sinc
plc
cell
appear
entri
compet
reason
degre
significantli
reduc
permiss
hcvcc
infect
compar
cell
may
due
defect
hcv
rna
replic
determin
capac
support
hcv
rna
replic
plc
cell
transfect
hcv
genotyp
subgenom
replicon
vitrotranscrib
rna
coloni
format
determin
previous
describ
cell
hcv
replicon
could
readili
establish
cell
line
howev
ratio
coloni
format
vitrotranscrib
rna
consider
lower
plc
cell
compar
cell
figur
sinc
reduct
could
attribut
differ
transfect
effici
introduc
hcv
altern
mean
plc
cell
infect
medium
cell
replic
full
length
hcv
replicon
contain
infecti
hcvcc
capabl
confer
resist
newli
infect
cell
entri
achiev
replic
establish
unlik
result
obtain
follow
transfect
plc
cell
rna
number
coloni
establish
plc
cell
infect
compar
achiev
cell
figur
although
reduct
coloni
format
note
p
next
expand
plc
clone
quantifi
hcv
rna
level
clone
determin
steadyst
hcv
rna
replic
level
achiev
cell
line
rtqpcr
analysi
reveal
rel
similar
level
hcv
rna
replic
three
cell
line
signific
differ
p
valu
mean
hcv
rna
intracellular
rna
observ
plc
clone
figur
vs
respect
likewis
signific
differ
p
valu
level
intracellular
hcv
rna
clone
observ
plc
clone
figur
vs
hcv
rna
respect
importantli
sinc
coloni
format
follow
infect
depend
success
viral
entri
effici
hcv
rna
replic
fact
similar
number
coloni
equal
level
hcv
rna
replic
achiev
plc
compar
cell
would
indic
despit
individu
differ
effici
hcv
entri
hcv
replic
cell
line
togeth
cumul
effici
hcvcc
entri
plu
subsequ
rna
replic
rel
equival
plc
cell
thu
allow
equival
stabl
infect
initi
event
occur
ie
coloni
format
howev
rule
possibl
infect
could
select
popul
plc
cell
enhanc
effici
viral
entri
andor
replic
cure
plc
replicon
clone
ifntreat
reassess
permiss
hcvcc
infect
shown
addit
file
figur
none
ifncur
clone
show
enhanc
permiss
hcvcc
infect
compar
parent
control
thu
far
result
indic
cumul
earli
event
hcv
infect
ie
entri
plu
replic
initi
equival
margin
reduc
plc
respect
compar
cell
therefor
log
reduct
hcvcc
permiss
observ
plc
cell
line
respect
figur
like
attribut
defect
post
replic
step
assembl
andor
egress
de
novo
hcvcc
monitor
multipl
round
hcv
infect
spread
depend
hcv
assembl
egress
perform
kinet
analysi
hcv
infect
cours
day
plc
cell
infect
hcvcc
low
moi
figur
use
approach
show
intracellular
hcv
rna
level
figur
cell
infect
hcvcc
moi
ffucel
reach
rna
one
day
pi
increas
exponenti
thereaft
reach
steadyst
level
rna
day
pi
hcvinfect
plc
cell
show
parallel
slightli
reduc
hcv
rna
expans
kinet
first
h
pi
compar
hcvinfect
cell
howev
day
pi
hcv
rna
level
began
declin
reach
undetect
level
day
pi
hcvinfect
cell
follow
log
increas
hcv
rna
level
first
h
pi
hcv
rna
reach
maintain
low
steadyst
level
rna
similarli
cell
clearli
lack
notabl
robust
expans
hcv
rna
level
h
pi
maintain
low
steadyst
level
rna
day
pi
likewis
entri
bypass
transfect
cell
infecti
fulllength
hcv
vitrotranscrib
rna
similar
profil
rna
expans
kinet
observ
addit
file
figur
analysi
hcvposit
cell
immunocytochem
stain
hcv
protein
day
pi
figur
indic
major
cell
cultur
becom
infect
small
percentag
cell
plc
cultur
infect
like
repres
cell
initi
infect
viral
inoculum
sinc
viral
spread
larg
extent
mediat
de
novo
secret
infecti
hcv
virion
next
quantifi
level
infecti
hcvcc
secret
supernat
infect
cell
line
cours
day
figur
use
standard
hcv
foci
format
assay
describ
infecti
hcvcc
detect
cultur
reduc
level
infecti
hcvcc
undetect
ie
lower
limit
assay
cultur
supernat
hcvinfect
plc
cell
even
day
plc
cultur
amplifi
higher
level
intracellular
hcv
rna
cell
figur
distinguish
whether
lack
infecti
hcvcc
present
supernat
hcvinfect
plc
cell
figur
due
defect
intracellular
hcv
rna
encapsid
virion
assembl
andor
ii
releas
de
novo
infecti
hcvcc
infect
plc
cell
hcvcc
moi
ffu
collect
cell
cultur
medium
infect
cultur
cours
day
quantifi
intracellular
extracellular
hcvcc
infect
titer
viral
rna
consist
data
shown
day
low
moi
infect
experi
figur
increas
infecti
hcvcc
level
detect
supernat
hcvinfect
cell
howev
time
pi
detect
infecti
hcvcc
cultur
supernat
hcvinfect
plc
cell
figur
determin
whether
noninfecti
hcvcc
virion
secret
infect
plc
cell
supernat
treat
micrococc
nucleas
rna
extract
hcv
genom
copi
quantifi
rtqpcr
shown
figur
extracellular
nucleaseprotect
hcv
rna
ie
encapsid
viral
rna
detect
cultur
supernat
harvest
hcvinfect
cell
level
exponenti
increas
cours
infect
consist
product
excret
de
novo
infecti
hcvcc
hcvinfect
plc
cell
howev
significantli
lower
level
nucleaseprotect
hcv
rna
detect
modest
exponenti
increas
total
copi
observ
day
notabl
hcv
rna
present
plc
cell
supernat
reflect
infecti
hcvcc
level
infect
ffuml
would
level
detect
titrat
assay
ffuml
thu
conclud
whether
low
level
hcv
rna
secret
plc
cell
repres
infecti
noninfecti
virion
assess
presenc
infect
intracellular
hcv
virion
cell
wash
extens
pb
trypsin
resuspend
cdmem
pellet
rpm
min
resuspend
cell
pellet
subject
multipl
freez
thaw
cell
debri
remov
centrifug
presenc
infecti
hcvcc
clear
lysat
determin
foci
titrat
analysi
presenc
noninfecti
hcv
rna
analysi
follow
micrococc
nucleas
treatment
expect
increas
level
infecti
hcvcc
nucleaseprotect
hcv
rna
detect
intracellular
lysat
hcvinfect
cell
cours
infect
figur
respect
hcvinfect
plc
cell
low
level
infecti
hcvcc
detect
day
pi
figur
similar
level
extracellular
hcv
rna
detect
cultur
supernat
figur
low
level
nucleaseprotect
hcv
rna
detect
intracellular
lysat
modest
exponenti
increas
total
copi
observ
day
togeth
data
indic
abil
plc
cell
effici
encapsid
hcv
rna
markedli
reduc
compar
cell
result
low
undetect
level
secret
infecti
de
novo
hcvcc
virus
often
induc
cellular
innat
immun
respons
mediat
induct
ifnstimul
gene
isg
infect
host
cell
although
cellular
isg
pathway
induc
viral
infect
gener
similar
among
mammalian
cell
review
differ
cell
line
possess
differ
abil
mount
specif
antivir
respons
viru
potenti
caus
differ
permiss
viral
infect
recent
demonstr
zhao
et
al
murin
coronaviru
infect
differ
murin
cell
line
determin
hcv
differenti
induc
express
isg
plc
cell
follow
infect
evalu
mrna
induct
rtqpcr
follow
infect
cell
hcvcc
moi
ffucel
shown
figur
mrna
level
upregul
hcvinfect
cell
remain
constant
throughout
cours
infect
indic
previous
shown
hcvcc
induc
effici
innat
interferon
respons
cell
contrast
induct
observ
three
human
hepatoma
cell
line
follow
hcvcc
infect
specif
mrna
level
upregul
cell
respect
earli
h
pi
reach
steadi
state
level
day
post
infect
highest
signific
induct
howev
observ
hcvinfect
plc
cell
notabl
previous
shown
ifnmedi
activ
innat
cellular
interferon
respons
inhibit
hcv
rna
replic
subsequ
product
de
novo
hcv
virion
data
shown
thu
reduc
steadyst
hcvcc
infect
level
observ
cell
declin
hcv
infect
observ
plc
cell
despit
cell
exhibit
compar
infect
initi
permiss
may
least
part
consequ
hcvinduc
innat
immun
signal
hepatoma
cell
line
consid
phenotyp
differ
observ
among
hepatoma
cell
line
addit
file
figur
percept
cell
rel
uniqu
abil
support
hcv
infect
base
previou
report
demonstr
vari
degre
hcvcc
infect
hepatoma
cell
line
heparg
immort
human
hepatoma
ihh
cell
surpris
hcvcc
infect
replic
could
readili
detect
plc
cell
figur
fact
hcv
rna
level
exceed
rna
detect
plc
cell
day
post
infect
hcvcc
compar
directli
cell
howev
appar
hcvcc
infect
plc
cell
reduc
vs
rna
respect
addit
initi
screen
also
show
notabl
differ
permiss
hcvpp
infect
two
cell
line
specif
hcvpp
infect
lower
plc
cell
compar
hcvppinfect
cell
howev
although
signific
p
valu
jfhpp
respect
seen
similar
variabl
permiss
hcvpp
infect
even
among
fulli
hcvccpermiss
cell
line
differ
laboratori
addit
file
figur
indic
level
hcv
entri
suffici
support
robust
hcvcc
infect
consist
hypothesi
permiss
hcvcc
infect
initi
notabl
higher
plc
cell
compar
hcvinfect
cell
figur
despit
lower
permiss
plc
hcvpp
entri
figur
taken
togeth
result
initi
screen
figur
indic
plc
cell
inde
permiss
hcvpp
hcvcc
infect
howev
differ
permiss
compar
cell
cell
line
exist
thu
initi
systemat
analysi
plc
permiss
hcvcc
infect
perform
experi
focus
differ
step
viral
lifecycl
ie
entri
replic
egress
spread
hcv
entri
determin
differ
hcvpp
hcvcc
infect
hepatoma
cell
line
could
attribut
entri
factor
alreadi
shown
modul
hcv
permiss
hepatoma
cell
line
examin
express
four
essenti
hcv
entri
factor
ie
srbi
ocln
rtqpcr
flow
cytometr
immunofluoresc
analysi
figur
interestingli
data
indic
compar
fulli
permiss
cell
line
obviou
differ
mrna
level
cell
surfac
express
srbi
ocln
observ
plc
cell
addit
overexpress
four
hcv
entri
factor
cell
line
sinc
other
shown
express
hcv
entri
factor
tran
enhanc
hcvpp
hcvcc
entri
cell
hcv
permiss
low
consist
observ
cell
line
alreadi
express
necessari
level
four
hcv
entri
factor
overexpress
srbi
ocln
individu
combin
significantli
increas
hcvpp
hcvcc
entri
hepatoma
cell
line
figur
henc
current
data
indic
panel
hepatoma
cell
line
express
minimum
set
known
entri
factor
necessari
effici
hcv
entri
howev
rule
possibl
cell
test
defici
anoth
hcv
entri
factor
eg
transferin
receptor
protein
niemannpick
cholesterol
absorpt
receptor
recent
show
hcv
entri
factor
entri
cofactor
eg
epiderm
growth
factor
receptor
ephrin
receptor
post
entri
host
cellular
protein
requir
effici
viral
fusion
nucleocapsid
uncoat
ii
hcv
rna
replic
examin
hcv
replic
independ
inher
differ
plc
cell
transfect
effici
took
advantag
viru
use
establish
hcv
replicon
cell
via
direct
infect
cell
rather
electropor
use
approach
coloni
form
plc
cultur
respect
week
follow
infect
ffu
figur
addit
analysi
hcv
rna
replic
level
select
clone
reveal
compar
level
hcv
rna
replic
achiev
three
cell
line
figur
likewis
similar
level
intracellular
hcv
rna
achiev
replicon
cell
clone
figur
importantli
sinc
coloni
format
follow
infect
depend
success
viral
entri
effici
hcv
rna
replic
fact
similar
number
coloni
equal
level
hcv
rna
replic
achiev
plc
cell
compar
cell
indic
cumul
effici
viral
entri
plu
subsequ
rna
replic
initi
rel
equival
plc
cell
iii
spread
infecti
hcvcc
product
perform
day
low
moi
infect
assay
abl
assess
effici
viral
spread
assess
intracellular
hcv
rna
expans
rel
de
novo
infecti
hcvcc
product
visual
viral
spread
directli
immunostain
hcvposit
cell
analysi
hcv
rna
replic
follow
infect
cell
line
hcvcc
figur
electropor
fulllength
infecti
hcv
vitrotranscrib
rna
addit
file
figur
reveal
intracellular
hcv
rna
initi
increas
infectedtransfect
cell
cultur
differ
rate
cultur
hcv
rna
level
continu
increas
exponenti
past
day
post
infectiontransfect
notabl
exponenti
increas
viral
rna
cultur
day
pi
would
requir
spread
viru
origin
infectedtransfect
cell
consist
hcv
stain
day
posthcvcc
infect
reveal
vast
major
cell
hcvposit
littl
spread
evid
plc
cell
cultur
figur
thu
infect
could
initi
cell
line
cell
appear
support
effici
viral
spread
sinc
spread
hcv
cell
follow
infect
depend
secret
de
novo
infecti
virion
measur
infecti
hcvcc
supernat
infect
cultur
observ
detect
reduc
level
infecti
hcvcc
cultur
supernat
undetect
level
hcvcc
infect
plc
cultur
figur
low
steadyst
level
intracellular
hcv
rna
infecti
viru
product
cell
could
result
defectbottleneck
phase
viral
life
cycl
eg
reduc
andor
isg
inhibit
entri
replic
secret
howev
sinc
cumul
effici
viral
entri
plu
subsequ
initi
hcv
rna
replic
appear
rel
equival
cell
figur
reason
specul
robust
hcv
infect
cell
may
limit
decreas
capac
viru
product
compar
cell
cours
case
plc
cell
clear
sever
defect
hcvcc
viru
product
infecti
particl
detect
supernat
infect
cultur
figur
analysi
hcvcc
present
within
cell
reveal
low
undetect
level
intracellular
infecti
virion
figur
compar
low
level
encapsid
hcv
rna
extra
intracellular
sampl
figur
suggest
virion
assembl
restrict
genom
encapsid
reduc
abil
plc
cell
cultur
support
robust
steadyst
infect
level
spread
hcvcc
like
multifactori
could
directli
due
influenc
lack
suffici
level
cellular
protein
necessari
effici
product
infecti
progeni
viru
consequ
presenc
inhibitori
factor
isg
induct
sinc
induct
innat
immun
signal
neg
affect
multipl
step
hcv
lifecycl
assess
abil
plc
cell
mount
innat
immun
respons
hcv
infect
measur
mrna
induct
repres
isg
follow
hcvcc
infect
importantli
induct
observ
cell
previous
publish
mrna
upregul
hcvinfect
plc
cell
plc
cell
exhibit
signific
induct
follow
hcvcc
infect
figur
although
gener
believ
cultur
hepatoma
cell
gener
impair
poli
ic
virusactiv
ifn
respons
result
consist
previou
find
promot
activ
potent
induc
cell
cell
follow
either
liposomemedi
transfect
poli
ic
sendai
viru
infect
relev
recent
public
marukian
et
al
show
correl
innat
antivir
gene
induct
impair
hcv
replic
spread
primari
liver
cell
likewis
hcv
spread
observ
highli
differenti
microscal
primari
human
hepatocyt
cultur
describ
ploss
et
al
specul
express
viral
protein
initi
infect
cell
might
suffici
blunt
intracellular
antivir
signal
allow
sustain
viral
replic
interferon
produc
infect
cell
may
suffici
signal
toactiv
adjac
cell
render
resist
infect
thu
limit
subsequ
viral
spread
thu
differ
isg
induct
observ
cell
line
figur
may
keep
hcv
replic
lower
per
cell
basi
andor
higher
level
success
inhibit
viral
replic
infect
cell
suffici
contribut
clearanc
infect
plc
ii
isg
well
known
neg
determin
hcv
permiss
numer
posit
determin
requir
effici
hcv
replic
also
identifi
review
although
overlap
independ
studi
often
observ
leav
relev
mani
factor
confirm
new
data
multipl
laboratori
recent
demonstr
human
micro
rna
critic
liverspecif
factor
requir
robust
hcv
infect
secret
ifn
treatment
shown
reduc
express
cell
possibl
enhanc
isg
induct
observ
three
cell
line
may
potent
reduc
import
posit
regul
hcv
infect
likewis
shown
play
import
role
regul
cholesterol
homeostasi
fatti
acid
metabol
lipogenesi
three
lipid
metabol
pathway
shown
necessari
hcv
replic
assembl
secret
fact
prior
submit
manuscript
evan
colleagu
matsuura
colleagu
separ
show
exogen
express
human
cell
respect
result
robust
hcv
replic
infecti
viru
secret
follow
hcvcc
inocul
hcv
rna
transfect
henc
lack
adequ
may
also
contribut
reduc
hcv
permiss
certain
cell
line
summari
test
panel
human
hepatoma
nonhepatoma
cell
hcvcc
permiss
identifi
new
cell
line
capabl
support
authent
hcvcc
infect
eg
entri
replic
protein
express
least
cell
de
novo
virion
product
permiss
plc
cell
hcvcc
infect
clearli
less
robust
achiev
highli
hcvccpermiss
cell
line
studi
need
definit
quantit
assess
host
cell
factor
limit
hcv
infect
cell
two
hepatoma
cell
line
nonetheless
provid
new
vitro
tool
elucid
cellular
factor
control
mediat
hcv
infect
particularli
associ
hcv
isg
induct
involv
de
novo
hcvcc
product
secret
addit
hcv
subgenom
fulllength
replicon
previous
establish
plc
cell
thu
clone
gener
studi
add
current
repertoir
subgenom
fulllength
hcv
replicon
alreadi
avail
studi
specif
aspect
hcv
life
cycl
hcv
polyprotein
process
replic
complex
format
hcv
rna
replic
expand
arsen
reagent
cell
line
amend
studi
hcv
certainli
advanc
overal
understand
hcv
viral
life
cycl
cellular
determin
involv
facilit
potenti
develop
new
specif
hcv
antivir
cell
previous
describ
follow
cell
purchas
american
type
cultur
collect
cell
cell
hela
cell
cell
cell
cell
kindli
provid
dr
lijun
rong
univers
illinoi
chicago
chicago
il
cell
dr
waddah
alrefai
univers
illinoi
chicago
chicago
il
human
cell
line
cultur
complet
dulbecco
modifi
eagl
medium
dmem
hyclon
logan
ut
cell
cultur
ham
medium
gibco
invitrogen
carlsbad
ca
media
supplement
fetal
bovin
serum
fb
hyclon
unitsml
penicillin
mgml
streptomycin
mm
lglutamin
gibco
invitrogen
case
hcv
replicon
cell
invitrogen
cell
culturepropag
hcv
hcvcc
viral
stock
obtain
infect
cell
multipl
infect
moi
focu
form
unit
ffu
cell
use
medium
cell
electropor
vitrotranscrib
full
length
infecti
hcv
rna
previous
describ
genotyp
infecti
full
length
fl
replicon
pfljfh
subgenom
sg
replicon
psgjfh
plasmid
kindli
provid
dr
wakita
nation
institut
infecti
diseas
tokyo
japan
previous
describ
human
human
srbi
pzeohsrbi
human
human
ocln
express
plasmid
previous
describ
pseudotyp
virus
produc
previous
describ
briefli
pseudotyp
virus
gener
cotransfect
dna
vector
encod
hcv
vesicular
stomat
viru
vsv
envelop
glycoprotein
envdefici
hiv
vector
carri
luciferas
report
gene
e
produc
cell
plasmid
use
pseudotyp
viru
gener
describ
previous
supernat
collect
h
post
transfect
filter
filter
bd
bioscienc
aliquot
frozen
subsequ
titer
use
quicktit
lentiviru
titer
kit
cell
biolab
inc
san
diego
ca
accord
manufactur
instruct
infect
cell
seed
h
prior
infect
plate
cell
confluenc
time
infect
triplic
well
inocul
equal
titer
jfhpp
vsvgpp
h
wash
twice
pb
follow
infect
overlaid
cdmem
h
pi
cultur
lyse
lysi
reagent
measur
luciferas
activ
promega
madison
wi
use
fluostar
optima
micropl
reader
bmg
labtechnolog
inc
durham
nc
pseudotyp
viru
experi
present
herein
backgroundcorrect
bc
hcvpp
rlu
valu
normal
correspond
bccorrect
vsvgpp
rlu
valu
hcvppbc
vsvgbc
infect
cell
line
cell
line
seed
h
prior
infect
plate
cell
confluenc
time
infect
triplic
well
inocul
hcvcc
moi
ffucel
h
pi
total
cellular
rna
isol
revers
transcript
follow
realtim
quantit
pcr
analysi
rtqpcr
low
moi
hcv
rna
kinet
analysi
cell
seed
h
prior
infect
plate
cell
confluenc
time
infect
triplic
well
infect
hcv
moi
ffucel
day
infect
assay
infect
cell
trypsin
reach
confluenc
replat
dilut
maintain
activ
growth
indic
time
pi
medium
andor
cellular
rna
harvest
triplic
well
titrat
rtqpcr
analysi
respect
total
intracellular
rna
isol
nucleic
acid
purif
lysi
solut
appli
biosystem
foster
citi
ca
purifi
use
abi
nucleic
acid
prepstat
appli
biosystem
per
manufactur
instruct
extracellular
rna
cell
supernat
intracellular
hcv
rna
lyse
cell
pellet
treat
unit
micrococc
nucleas
fermenta
glen
burni
md
min
room
temperatur
nucleasetr
rna
isol
guanidin
thiocyan
gtc
method
use
gtc
contain
murin
total
liver
rna
follow
standard
protocol
one
purifi
rna
use
cdna
synthesi
use
taqman
revers
transcript
reagent
appli
biosystem
follow
sybr
green
rtqpcr
use
appli
biosystem
realtim
thermocycl
appli
biosystem
thermal
cycl
consist
initi
min
denatur
step
follow
cycl
denatur
annealingextens
min
hcv
human
gapdh
murin
gapdh
human
human
srbi
human
human
ocln
human
rna
level
determin
rel
standard
curv
compris
serial
dilut
plasmid
contain
hcv
cdna
human
gapdh
murin
gapdh
human
human
srbi
human
human
ocln
human
code
sequenc
respect
pcr
primer
use
amplifi
respect
amplicon
univers
hcv
primer
tag
cca
tgg
cgt
tag
ta
sens
ctc
ccg
ggg
cactcg
caa
antisens
human
gapdh
ggt
gaa
ggt
cgg
agt
sens
gat
ggt
gat
ggg
att
antisens
murin
gapdh
gga
aag
ctg
tgg
cgt
sens
gtg
agc
ttc
ccg
ttc
antisens
human
tcc
tgt
atc
tgg
agc
sens
gcg
atc
tgg
tcc
ttg
antisens
human
srbi
cag
gca
ttg
gac
aaa
sens
ctt
atc
ctt
tga
gcc
ctt
antisens
human
gtg
gag
gat
tta
ctc
cta
tgc
sens
atc
aag
gca
cgg
gtt
gct
antisens
human
ocln
tca
aac
cga
atc
att
atg
cac
sens
aga
tgg
caa
tgc
aca
tca
antisens
human
ggg
cag
act
ggc
aga
agc
sens
tat
agc
gga
agg
gat
ttg
aaa
gc
antisens
cell
resuspend
fac
buffer
pb
contain
vv
fb
wv
mm
edta
incub
min
dilut
antibodi
specif
abd
serotec
srbi
bd
bioscienc
follow
three
rins
fac
buffer
bound
antibodi
detect
incub
h
phycoerythrin
pe
conjug
antimous
bd
pharmingen
antibodi
dilut
cell
stain
irrelev
mous
immunoglobulin
g
igg
antibodi
respect
peconjug
secondari
antibodi
serv
neg
control
cell
wash
three
time
fix
fac
buffer
contain
wv
pfa
analyz
flow
cytometri
use
dakocytom
cyan
system
dako
carpinteria
ca
summit
softwar
dako
cell
fix
pfa
sigma
st
loui
mo
indic
time
immunofluoresc
analysi
perform
previous
describ
briefli
fix
cultur
rins
three
time
pb
permeabil
aceton
vv
fisher
subsequ
block
h
pb
contain
wv
bovin
serum
albumin
bsa
sigma
vv
fb
cell
stain
dilut
mous
antihuman
abnova
taipei
taiwan
mous
antihuman
ocln
zyme
san
francisco
ca
primari
antibodi
overnight
follow
incub
dilut
antimous
conjug
secondari
antibodi
molecular
probe
h
room
temperatur
cell
nuclei
stain
hoechst
dye
bound
antibodi
visual
via
confoc
microscopi
zeiss
lsm
germani
compar
neg
control
sampl
stain
irrelev
mous
control
antibodi
santa
cruz
biotechnolog
conjug
secondari
antibodi
imag
analyz
use
zeiss
lsm
alpha
imag
browser
softwar
zeiss
bright
contrast
adjust
use
san
jose
ca
hcv
sg
fl
replicon
establish
previous
describ
briefli
vitrotranscrib
hcv
genotyp
replicon
rna
transfect
cell
use
modifi
electropor
protocol
transfect
cell
dilut
seed
mm
tissu
cultur
dish
maintain
presenc
invitrogen
concentr
cell
die
distinct
cell
coloni
form
visual
coloni
format
cell
fix
ethanol
stain
crystal
violet
altern
coloni
expand
establish
replicon
cell
line
harvest
stabl
fl
replicon
cell
infect
titer
determin
describ
cultur
supernat
serial
dilut
use
infect
cultur
h
pi
cultur
overlay
complet
dmem
contain
final
concentr
methylcellulos
fluka
biochemika
switzerland
seventytwo
hour
pi
cell
fix
paraformaldehyd
sigma
immunohistochem
stain
hcv
use
human
monoclon
antibodi
gift
dr
mansun
law
denni
burton
scripp
research
institut
describ
viral
titer
express
ffuml
determin
averag
foci
number
detect
highest
hcvposit
dilut
quantifi
intracellular
hcvcc
hcvinfect
cell
cultur
wash
three
time
pb
trypsin
min
room
temperatur
cell
resuspend
ml
cdmem
cell
pellet
rpm
min
frozen
thaw
three
time
use
ethanol
dri
ice
bath
sampl
centrifug
rpm
min
remov
cell
debri
supernat
fraction
use
titrat
infecti
hcvcc
hcv
rna
analysi
describ
data
present
mean
standard
deviat
sd
signific
differ
determin
oneway
analysi
varianc
anova
follow
tukey
post
hoc
test
graphpad
softwar
hcv
hepat
c
viru
hcc
hepatocellular
carcinoma
japanes
fulmin
hepat
hcvcc
hepat
c
viru
cellcultur
produc
hcvpp
hcv
pseudotyp
particl
vsvgpp
vesicular
stomat
viru
g
protein
pseudotyp
particl
sg
subgenom
fl
fulllength
moi
multipl
infect
ffu
focu
form
unit
rtqpcr
realtim
quantit
pcr
srbi
scaveng
receptor
class
b
member
ocln
occludin
pi
post
infect
isg
interferon
stimul
gene
author
declar
compet
interest
bs
slu
design
studi
draft
manuscript
bs
nb
xy
pc
perform
experi
particip
data
analysi
author
read
approv
final
manuscript
